Viewing Study NCT06525350

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-02-02 @ 8:28 AM
Study NCT ID: NCT06525350
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-29
First Post: 2024-07-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung Cancer
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced/Recurrent or Distant Metastasized Non-small Cell Lung Cancer With … View
Keywords: